Literature DB >> 30955176

Association of History of Injection Drug Use with External Cause-Related Mortality Among Persons Linked to HIV Care in an Urban Clinic, 2001-2015.

Kanal Singh1, Geetanjali Chander2, Bryan Lau1, Jessie K Edwards3, Richard D Moore1,2, Catherine R Lesko4.   

Abstract

High mortality rates among persons with HIV with a history of injection drug use (PWID) are thought to be driven in part by higher rates of external cause-related mortality. We followed 4796 persons aged 18-70 engaged in continuity HIV care from 2001 to 2015 until death or administrative censoring. We compared cause-specific (csHR) and subdistribution hazards (sdHR) of death due to external causes among PWID and persons who acquired their HIV infection through other routes (non-IDU). We standardized estimates on age, sex, race, and HIV-related health status. The standardized csHR for external cause-related death was 3.57 (95% CI 2.39, 5.33), and the sdHR was 3.14 (95% CI 2.16, 4.55). The majority of external cause-related deaths were overdose-related and standardized sdHR was 4.02 (95% CI 2.40, 6.72). Absolute rate of suicide was low but the csHR for PWID compared to non-IDU was most elevated for suicide (6.50, 95% CI 1.51, 28.03). HIV-infected PWID are at a disproportionately increased risk of death due to external causes, particularly overdose and suicide.

Entities:  

Keywords:  Cause-specific mortality; Competing risks; Injection drug use; Injury-related mortality; Survival

Mesh:

Year:  2019        PMID: 30955176      PMCID: PMC6778696          DOI: 10.1007/s10461-019-02497-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  55 in total

1.  Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure.

Authors:  K Lu; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

Review 2.  The world report on violence and health.

Authors:  Etienne G Krug; James A Mercy; Linda L Dahlberg; Anthony B Zwi
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

3.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Authors:  A Mocroft; B Ledergerber; C Katlama; O Kirk; P Reiss; A d'Arminio Monforte; B Knysz; M Dietrich; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

4.  Tobacco, alcohol, cannabis and other illegal drug use among young adults: the socioeconomic context.

Authors:  Bertrand Redonnet; Aude Chollet; Eric Fombonne; Lucy Bowes; Maria Melchior
Journal:  Drug Alcohol Depend       Date:  2011-09-28       Impact factor: 4.492

5.  A prospective study of alcohol consumption and HIV acquisition among injection drug users.

Authors:  Chanelle J Howe; Stephen R Cole; David G Ostrow; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

6.  Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

Authors:  R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

7.  A case study of the impact of inaccurate cause-of-death reporting on health disparity tracking: New York City premature cardiovascular mortality.

Authors:  Lauren E Johns; Ann M Madsen; Gil Maduro; Regina Zimmerman; Kevin Konty; Elizabeth Begier
Journal:  Am J Public Health       Date:  2012-09-20       Impact factor: 9.308

8.  Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992.

Authors:  A Fugelstad; A Annell; J Rajs; G Agren
Journal:  Acta Psychiatr Scand       Date:  1997-09       Impact factor: 6.392

9.  The quality of death certification practice in Greece.

Authors:  G Filippatos; P Andriopoulos; G Panoutsopoulos; S Zyga; K Souliotis; V Gennimata; M Tsironi
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

10.  Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.

Authors:  Inés Suárez-García; Paz Sobrino-Vegas; David Dalmau; Rafael Rubio; José Antonio Iribarren; José Ramón Blanco; Félix Gutierrez; Marta Montero Alonso; Enrique Bernal; David Vinuesa García; Julia Del Amo
Journal:  Addiction       Date:  2016-04-14       Impact factor: 6.526

View more
  4 in total

1.  Sex stratification of the trends and risk of mortality among individuals living with HIV under different transmission categories.

Authors:  Chun-Yuan Lee; Yi-Pei Lin; Hung-Pin Tu; Sheng-Fan Wang; Po-Liang Lu
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

2.  A Systematic Review of Risk Factors for Suicide Among Persons Living with HIV (1996-2020).

Authors:  Alexandria Smith; Stephen Breazeale; Joseph L Goulet; David Vlahov; Amy C Justice; Julie A Womack
Journal:  AIDS Behav       Date:  2022-02-02

3.  Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.

Authors:  Simeon D Kimmel; Alexander Y Walley; Sara Lodi; Leah S Forman; Jane M Liebschutz; Marlene C Lira; Theresa W Kim; Carlos Del Rio; Jeffrey H Samet; Judith I Tsui
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

4.  Disability-adjusted life years and mortality rate attributed to unsafe sex and drug use for AIDS in the Middle East and North Africa countries.

Authors:  Farid Najafi; Fatemeh Khosravi Shadmani; Mojtaba Ghalandari; Mitra Darbandi
Journal:  Arch Public Health       Date:  2020-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.